CRVO logo

CervoMed (CRVO) Cash From Operations

Annual CFO

-$7.45 M
-$4.88 M-189.56%

December 31, 2023

Summary

Performance

1-Year Change

-189.56%

3-Year Change

+45.03%

5-Year Change

+30.85%

15-Year Change

+39.59%

CRVO Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.38%
CRVO annual cash flow from operations is higher than 64.38% of companies in Healthcare sector

High & Low

All-time High

$0.00
CRVO annual cash flow from operations is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$14.50 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CRVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 1, 2025
CRVO next annual earnings announcement is scheduled for Apr 1, 2025

OtherCRVOcash flowmetrics:

Annual CFI

-
CRVO annual cash flow from investing activities value is unknown

Annual CFF

$11.15 M
CRVO annual cash flow from financing activities is $11.15 million

Annual FCF

-$7.45 M
CRVO annual free cash flow is -$7.45 million

Annual CAPEX

-
CRVO annual capital expenditures value is unknown

Quarterly CFO

-$4.85 M
-$2.65 M-120.50%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-240.98%

3-Year Change

-240.98%

5-Year Change

-240.98%

CRVO Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.6%
CRVO quarterly cash flow from operations is higher than 46.6% of companies in Healthcare sector

High & Low

All-time High

$6.86 M
CRVO quarterly cash flow from operations is currently -170.80% below its historical high of $6.86 million

3-Year Low

-$4.85 M
CRVO quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
CRVO next earnings announcement is scheduled for Apr 1, 2025

OtherCRVOcash flowmetrics:

Quarterly CFI

$2.60 M
CRVO quarterly cash flow from investing activities is $2.60 million

Quarterly CFF

-$13.30 K
CRVO quarterly cash flow from financing activities is -$13.30 thousand

Quarterly FCF

-$4.85 M
CRVO quarterly free cash flow is -$4.85 million

Quarterly CAPEX

-
CRVO quarterly capital expenditures value is unknown

TTM CFO

-$11.02 M
-$3.39 M-44.38%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-49.06%

3-Year Change

-49.06%

5-Year Change

-49.06%

CRVO TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.96%
CRVO TTM cash flow from operations is higher than 57.96% of companies in Healthcare sector

High & Low

All-time High

$2.72 M
CRVO TTM cash flow from operations is currently -505.01% below its historical high of $2.72 million

3-Year Low

-$14.73 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CRVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
CRVO next earnings announcement is scheduled for Apr 1, 2025

OtherCRVOcash flowmetrics:

TTM CFI

-$37.97 M
CRVO TTM cash flow from investing activities is -$37.97 million

TTM CFF

$46.31 M
CRVO TTM cash flow from financing activities is $46.31 million

TTM FCF

-$11.02 M
CRVO TTM free cash flow is -$11.02 million

TTM CAPEX

-
CRVO TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CRVO Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-189.6%-241.0%-49.1%
3 y3 years+45.0%-241.0%-49.1%
5 y5 years+30.9%-241.0%-49.1%

CRVO Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-189.6%+48.6%-170.8%at low-505.0%+25.2%
5 y5-year-189.6%+48.6%-170.8%+6.2%-505.0%+28.5%
alltimeall time<-9999.0%+48.6%-170.8%+6.2%-505.0%+28.5%

CervoMed Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.85 M(+120.5%)
-$11.02 M(+44.4%)
Jun 2024
-
-$2.20 M(+54.6%)
-$7.63 M(+3.2%)
Mar 2024
-
-$1.42 M(-43.9%)
-$7.39 M(-0.8%)
Dec 2023
-$7.45 M(+189.6%)
-$2.54 M(+73.0%)
-$7.45 M(+32.9%)
Sep 2023
-
-$1.47 M(-25.2%)
-$5.60 M(-306.0%)
Jun 2023
-
-$1.96 M(+32.4%)
$2.72 M(+302.9%)
Mar 2023
-
-$1.48 M(+114.0%)
$675.20 K(-126.2%)
Dec 2022
-$2.57 M(-82.3%)
-
-
Dec 2022
-
-$692.50 K(-110.1%)
-$2.57 M(-47.6%)
Sep 2022
-
$6.86 M(-271.1%)
-$4.91 M(-66.7%)
Jun 2022
-
-$4.01 M(-15.3%)
-$14.73 M(+4.8%)
Mar 2022
-
-$4.73 M(+56.3%)
-$14.06 M(-3.1%)
Dec 2021
-$14.50 M(+7.0%)
-$3.03 M(+1.8%)
-$14.50 M(-2.5%)
Sep 2021
-
-$2.97 M(-10.7%)
-$14.87 M(-3.5%)
Jun 2021
-
-$3.33 M(-35.7%)
-$15.41 M(+1.2%)
Mar 2021
-
-$5.18 M(+52.5%)
-$15.22 M(+12.3%)
Dec 2020
-$13.55 M(+37.5%)
-$3.39 M(-3.3%)
-$13.55 M(+7.6%)
Sep 2020
-
-$3.51 M(+11.7%)
-$12.60 M(+12.1%)
Jun 2020
-
-$3.14 M(-10.3%)
-$11.24 M(+5.0%)
Mar 2020
-
-$3.50 M(+43.7%)
-$10.71 M(+8.6%)
Dec 2019
-$9.86 M(-8.5%)
-$2.44 M(+13.2%)
-$9.86 M(-5.6%)
Sep 2019
-
-$2.15 M(-17.5%)
-$10.45 M(+2.3%)
Jun 2019
-
-$2.61 M(-1.8%)
-$10.21 M(+0.7%)
Mar 2019
-
-$2.66 M(-12.2%)
-$10.14 M(-5.9%)
Dec 2018
-$10.77 M(-12.6%)
-$3.03 M(+58.0%)
-$10.77 M(+7.4%)
Sep 2018
-
-$1.92 M(-24.6%)
-$10.03 M(-16.4%)
Jun 2018
-
-$2.54 M(-22.8%)
-$12.00 M(-1.7%)
Mar 2018
-
-$3.29 M(+44.1%)
-$12.21 M(-1.0%)
Dec 2017
-$12.33 M(+14.5%)
-$2.28 M(-41.3%)
-$12.33 M(+7.6%)
Sep 2017
-
-$3.89 M(+41.6%)
-$11.46 M(+21.4%)
Jun 2017
-
-$2.75 M(-19.6%)
-$9.44 M(-1.2%)
Mar 2017
-
-$3.42 M(+141.5%)
-$9.55 M(-11.3%)
Dec 2016
-$10.77 M(+107.7%)
-$1.41 M(-24.2%)
-$10.77 M(-7.3%)
Sep 2016
-
-$1.86 M(-34.8%)
-$11.62 M(+8.2%)
Jun 2016
-
-$2.86 M(-38.3%)
-$10.74 M(+21.0%)
Mar 2016
-
-$4.63 M(+104.3%)
-$8.88 M(+71.2%)
Dec 2015
-$5.19 M(-42.6%)
-$2.27 M(+130.8%)
-$5.19 M(+6.9%)
Sep 2015
-
-$981.70 K(-1.7%)
-$4.85 M(-17.1%)
Jun 2015
-
-$998.80 K(+6.4%)
-$5.85 M(-38.7%)
Mar 2015
-
-$938.80 K(-51.4%)
-$9.54 M(+5.6%)
Dec 2014
-$9.03 M
-$1.93 M(-2.5%)
-$9.03 M(+27.2%)
Sep 2014
-
-$1.98 M(-57.8%)
-$7.10 M(+30.2%)
DateAnnualQuarterlyTTM
Jun 2014
-
-$4.69 M(+983.0%)
-$5.45 M(+316.0%)
Mar 2014
-
-$432.90 K(>+9900.0%)
-$1.31 M(+10.7%)
Dec 2013
-$1.18 M(-72.5%)
-$600.00(-99.8%)
-$1.18 M(-55.8%)
Sep 2013
-
-$333.00 K(-38.9%)
-$2.68 M(-7.8%)
Jun 2013
-
-$544.80 K(+77.9%)
-$2.91 M(+5.0%)
Mar 2013
-
-$306.20 K(-79.6%)
-$2.77 M(-35.7%)
Dec 2012
-$4.31 M(-64.2%)
-$1.50 M(+167.8%)
-$4.31 M(-28.6%)
Sep 2012
-
-$559.30 K(+37.3%)
-$6.04 M(-39.2%)
Jun 2012
-
-$407.30 K(-77.9%)
-$9.93 M(-25.3%)
Mar 2012
-
-$1.85 M(-42.7%)
-$13.30 M(+10.6%)
Dec 2011
-$12.02 M(+507.0%)
-$3.22 M(-27.6%)
-$12.02 M(+30.8%)
Sep 2011
-
-$4.45 M(+17.9%)
-$9.19 M(+67.7%)
Jun 2011
-
-$3.78 M(+560.1%)
-$5.48 M(+149.5%)
Mar 2011
-
-$572.20 K(+46.3%)
-$2.20 M(+10.9%)
Dec 2010
-$1.98 M(+87.4%)
-$391.00 K(-47.3%)
-$1.98 M(+7.6%)
Sep 2010
-
-$741.90 K(+50.9%)
-$1.84 M(+32.3%)
Jun 2010
-
-$491.80 K(+38.0%)
-$1.39 M(+5.9%)
Mar 2010
-
-$356.40 K(+42.0%)
-$1.31 M(+24.2%)
Dec 2009
-$1.06 M(+108.9%)
-$250.90 K(-14.1%)
-$1.06 M(+9.8%)
Sep 2009
-
-$292.10 K(-29.4%)
-$962.50 K(+34.7%)
Jun 2009
-
-$413.90 K(+313.1%)
-$714.30 K(+40.3%)
Mar 2009
-
-$100.20 K(-35.9%)
-$509.10 K(+0.6%)
Dec 2008
-$506.00 K(<-9900.0%)
-$156.30 K(+256.0%)
-$506.00 K(-430.1%)
Sep 2008
-
-$43.90 K(-79.0%)
$153.30 K(-363.4%)
Jun 2008
-
-$208.70 K(+114.9%)
-$58.20 K(-931.4%)
Mar 2008
-
-$97.10 K(-119.3%)
$7000.00(-7100.0%)
Dec 2007
$0.00(0.0%)
$503.00 K(-296.9%)
-$100.00(-100.0%)
Sep 2007
-
-$255.40 K(+78.0%)
-$503.10 K(+103.1%)
Jun 2007
-
-$143.50 K(+37.7%)
-$247.70 K(+137.7%)
Mar 2007
-
-$104.20 K(<-9900.0%)
-$104.20 K(<-9900.0%)
Dec 2006
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2005
-$75.00 K(-99.1%)
-
-
Sep 2000
-
$812.30 K(-7.1%)
-$106.60 K(-97.7%)
Jun 2000
-
$874.10 K(-235.1%)
-$4.62 M(-40.7%)
Mar 2000
-
-$647.10 K(-43.5%)
-$7.79 M(-6.6%)
Dec 1999
-$8.35 M(+17.5%)
-$1.15 M(-69.0%)
-$8.35 M(+15.9%)
Sep 1999
-
-$3.70 M(+60.9%)
-$7.20 M(+105.7%)
Jun 1999
-
-$2.30 M(+91.7%)
-$3.50 M(+191.7%)
Mar 1999
-
-$1.20 M
-$1.20 M
Dec 1998
-$7.10 M
-
-

FAQ

  • What is CervoMed annual cash flow from operations?
  • What is the all time high annual CFO for CervoMed?
  • What is CervoMed annual CFO year-on-year change?
  • What is CervoMed quarterly cash flow from operations?
  • What is the all time high quarterly CFO for CervoMed?
  • What is CervoMed quarterly CFO year-on-year change?
  • What is CervoMed TTM cash flow from operations?
  • What is the all time high TTM CFO for CervoMed?
  • What is CervoMed TTM CFO year-on-year change?

What is CervoMed annual cash flow from operations?

The current annual CFO of CRVO is -$7.45 M

What is the all time high annual CFO for CervoMed?

CervoMed all-time high annual cash flow from operations is $0.00

What is CervoMed annual CFO year-on-year change?

Over the past year, CRVO annual cash flow from operations has changed by -$4.88 M (-189.56%)

What is CervoMed quarterly cash flow from operations?

The current quarterly CFO of CRVO is -$4.85 M

What is the all time high quarterly CFO for CervoMed?

CervoMed all-time high quarterly cash flow from operations is $6.86 M

What is CervoMed quarterly CFO year-on-year change?

Over the past year, CRVO quarterly cash flow from operations has changed by -$3.43 M (-240.98%)

What is CervoMed TTM cash flow from operations?

The current TTM CFO of CRVO is -$11.02 M

What is the all time high TTM CFO for CervoMed?

CervoMed all-time high TTM cash flow from operations is $2.72 M

What is CervoMed TTM CFO year-on-year change?

Over the past year, CRVO TTM cash flow from operations has changed by -$3.63 M (-49.06%)